Literature DB >> 26453790

Enhanced antioxidation via encapsulation of isooctyl p-methoxycinnamate with sodium deoxycholate-mediated liposome endocytosis.

Yongtai Zhang1, Lina Shen1, Kai Zhang1, Teng Guo1, Jihui Zhao1, Nana Li1, Nianping Feng2.   

Abstract

Isooctyl p-methoxycinnamate(OMC) is a commonly used chemical ultraviolet B sunscreen that suffers rapid degradation with current delivery systems following sun exposure. In this study, deoxycholate-mediated liposome (DOC-LS) endocytosis was employed to improve the antioxidation effects of OMC following topical administration, and the in vitro cell uptake was investigated to understand the enhanced cutaneous absorption of the drug via this nanocarrier. Following topical application, structural changes in the stratum corneum were identified. With the increase of DOC content, the drug deposition in skin decreased; from this, a DOC-LS formulation was selected that showed significantly more drug delivery in skin than did the other preparations (P<0.05). DOC-LS decreased skin resistance, suggesting its ability to induce skin barrier disruption. In vitro HaCaT keratinocyte cell uptake of coumarin-6 incorporated in the two types of phosphatidylcholine (PC) vesicles (i.e., LS or DOC-LS) yielded similar fluorescence intensities following incubation for different periods (P<0.05). However, CCC-ESF-1 embryonic fibroblast cell uptake of the fluorescence revealed time-dependence, and the emitted light from DOC-LS incubated cells was stronger than that from cells incubated with LS (P<0.05). These findings might be associated with the endocytic pathway of HaCaT, which mainly exhibited adsorption or physical adhesion of the fluorescent vesicles, whereas CCC-ESF-1 markedly internalized the PC vesicles via the lysosomes, as shown by intracellular fluorescence co-location studies. Following loading with the same amount of OMC, the DOC-LS vesicles exhibited superior skin tissue antioxidative capacity among the preparations tested, corroborating the in vivo skin drug deposition results. Thus, our results suggest that DOC-LS is a promising system for OMC dermal delivery without promoting skin irritation, which is quite advantageous for therapeutic purposes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell uptake; Methane dicarboxylic aldehyde; Superoxide dismutase; Transdermal; Transfersomes

Mesh:

Substances:

Year:  2015        PMID: 26453790     DOI: 10.1016/j.ijpharm.2015.10.010

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Pentapeptide modified ethosomes for enhanced skin retention and topical efficacy activity of indomethacin.

Authors:  Jiangxiu Niu; Ming Yuan; Hongying Li; Yao Liu; Liye Wang; Yanli Fan; Yansong Zhang; Xianghui Liu; Lingmei Li; Jingxiao Zhang; Chenyu Zhao
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

2.  DOC-LS, a new liposome for dermal delivery, and its endocytosis by HaCaT and CCC-ESF-1 cells.

Authors:  Yong-Tai Zhang; Kai Zhang; Zhe Li; Hong-Yu Zhang; Teng Guo; Yan-Yan Li; Ji-Hui Zhao; Nian-Ping Feng
Journal:  IET Nanobiotechnol       Date:  2018-12       Impact factor: 1.847

3.  Synergistic Protective Effect of Konjac Mannan Oligosaccharides and Bacillus subtilis on Intestinal Epithelial Barrier Dysfunction in Caco-2 Cell Model and Mice Model of Lipopolysaccharide Stimulation.

Authors:  Lupeng Chen; Shuai Zhang; Shi Wu; Zhuqing Ren; Guoquan Liu; Jian Wu
Journal:  Front Immunol       Date:  2021-09-17       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.